BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6099352)

  • 1. Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Itoh H; Hidaka H
    J Biochem; 1984 Dec; 96(6):1721-6. PubMed ID: 6099352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Holothurin: an activator of bovine brain 3'-5' phosphodiesterase.
    Vig PJ; Mehrotra BD; Desaiah D
    Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):419-22. PubMed ID: 1693008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calmodulin antagonists on hormone release and cyclic AMP levels in GH3 pituitary cells.
    Sletholt K; Haug E; Gordeladze J; Sand O; Gautvik KM
    Acta Physiol Scand; 1987 Jun; 130(2):333-43. PubMed ID: 3037857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-independent activation of calcium ion dependent cyclic nucleotide phosphodiesterase by synthetic compounds: quinazolinesulfonamide derivatives.
    Tanaka T; Yamada E; Sone T; Hidaka H
    Biochemistry; 1983 Mar; 22(5):1030-4. PubMed ID: 6301535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Ichimura M; Eiki R; Osawa K; Nakanishi S; Kase H
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):311-6. PubMed ID: 8645223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calmodulin activation of cyclic AMP phosphodiesterase in the B16 mouse melanoma.
    Walker SW; Mac Neil S; Senior HJ; Bleehen SS; Tomlinson S
    Biochem J; 1984 May; 219(3):941-6. PubMed ID: 6331402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two types of calmodulin antagonists: a structurally related interaction.
    Inagaki M; Hidaka H
    Pharmacology; 1984; 29(2):75-84. PubMed ID: 6089236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calmodulin-dependent cyclic AMP phosphodiesterase in liver plasma membranes: stimulated by insulin.
    Smoake JA; Moy GM; Fang B; Solomon SS
    Arch Biochem Biophys; 1995 Nov; 323(2):223-32. PubMed ID: 7487081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a calmodulin-dependent high-affinity cyclic AMP and cyclic GMP phosphodiesterase from male mouse germ cells.
    Geremia R; Rossi P; Mocini D; Pezzotti R; Conti M
    Biochem J; 1984 Feb; 217(3):693-700. PubMed ID: 6324744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.
    Ivorra MD; Lugnier C; Schott C; Catret M; Noguera MA; Anselmi E; D'Ocon P
    Br J Pharmacol; 1992 Jun; 106(2):387-94. PubMed ID: 1327380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of smooth muscle relaxant drugs with calmodulin and cyclic nucleotide phosphodiesterase.
    Ronca-Testoni S; Hrelia S; Hakim G; Rossi CA
    Experientia; 1985 Jan; 41(1):75-6. PubMed ID: 2981701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+ activated and pH sensitive cyclic AMP phosphodiesterase in the nervous system of the mollusc Pleurobranchaea.
    Calhoon RD; Gillette R
    Brain Res; 1983 Jul; 271(2):371-4. PubMed ID: 6311334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of mouse oocyte maturation: involvement of cyclic AMP phosphodiesterase and calmodulin.
    Bornslaeger EA; Wilde MW; Schultz RM
    Dev Biol; 1984 Oct; 105(2):488-99. PubMed ID: 6207062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca2+-dependent cyclic nucleotide phosphodiesterase is activated by poly(L-aspartic acid).
    Tanaka T; Ito M; Ohmura T; Hidaka H
    Biochemistry; 1985 Sep; 24(19):5281-4. PubMed ID: 3000429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of calmodulin-like activity in term human amnion: effect of calmodulin inhibitors on prostaglandin biosynthesis.
    Olson DM; Kramar D; Smieja Z
    J Dev Physiol; 1987 Jun; 9(3):271-85. PubMed ID: 3038990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):403-7. PubMed ID: 7144734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allosteric regulation of Ca2+-calmodulin-dependent phosphodiesterase activity from the bovine brain].
    Bobruskin ID; Shaĭkhin SM; Muratova MV; Baranova LA; Severin ES
    Biokhimiia; 1987 Aug; 52(8):1344-52. PubMed ID: 2822149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of multiple forms of cyclic nucleotide phosphodiesterase from bovine hypothalamus: new factors modulating enzyme activity.
    Galoyan AA; Gurvitz BYa
    Neurochem Res; 1985 Nov; 10(11):1467-81. PubMed ID: 3003614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by dihydropyridine calcium antagonists.
    Sharma RK; Wang JH; Wu Z
    J Neurochem; 1997 Aug; 69(2):845-50. PubMed ID: 9231746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the dihydropyridine calcium antagonist, CD-349, with calmodulin.
    Tanaka M; Muramatsu M; Aihara H; Otomo S
    Biochem Pharmacol; 1990 Sep; 40(5):991-6. PubMed ID: 2167684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.